Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICG Guided Tumor Resection in Pediatric Solid Tumors
NCT04084067Phase 1Completed
- Sponsor
- St. Jude Children's Research Hospital
- Start
- Feb 2020
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of indocyanine green in solid tumor and lymphoma, sponsored by St. Jude Children's Research Hospital. Primary endpoint: Sensitivity rates of the ICG guided neoplastic disease identification at 24 hours. Started Feb 2020; status: completed.
02
Drugs
indocyanine green
03
Conditions
solid tumorlymphoma
Beyond the preview
Go deeper on NCT04084067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04084067.